Structure and function of the mycobacterial transcription initiation complex with the essential regulator RbpA

  1. Elizabeth A Hubin
  2. Allison Fay
  3. Catherine Xu
  4. James M Bean
  5. Ruth M Saecker
  6. Michael S Glickman
  7. Seth A Darst  Is a corresponding author
  8. Elizabeth A Campbell  Is a corresponding author
  1. The Rockefeller University, United States
  2. Sloan-Kettering Institute, United States
  3. University of Cambridge, United States

Abstract

RbpA and CarD are essential transcription regulators in mycobacteria. Mechanistic analyses of promoter open complex (RPo) formation establish thatRbpA and CarD cooperatively stimulate formation of anintermediate (RP2) leading to RPo; formation of RP2 islikely a bottleneck step at the majority of mycobacterial promoters. Once RPo forms, CarD also disfavors its isomerization back to RP2.We determined a 2.76 Å-resolution crystal structure of a mycobacterial transcription initiation complex (TIC) with RbpA as well as a CarD/RbpA/TIC model. Both CarD and RbpA bind near the upstream edge of the -10 element where they likely facilitate DNA bending and impede transcription bubble collapse. In vivo studies demonstrate the essential role of RbpA, effects of RbpA truncations on transcription and cell physiology, and indicate additional functions for RbpA not evident in vitro. This work provides a framework to understand the control of mycobacterial transcriptionby RbpA and CarD.

Data availability

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Elizabeth A Hubin

    The Rockefeller University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Allison Fay

    Immunology Program, Sloan-Kettering Institute, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Catherine Xu

    Department of Chemistry, University of Cambridge, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. James M Bean

    Immunology Program, Sloan-Kettering Institute, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Ruth M Saecker

    Department of Chemistry, University of Cambridge, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Michael S Glickman

    Immunology Program, Sloan-Kettering Institute, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7918-5164
  7. Seth A Darst

    The Rockefeller University, New York, United States
    For correspondence
    darst@rockefeller.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8241-3153
  8. Elizabeth A Campbell

    The Rockefeller University, New York, United States
    For correspondence
    elizabeth.campbell0@gmail.com
    Competing interests
    The authors declare that no competing interests exist.

Funding

National Institutes of Health (RO1 GM114450)

  • Elizabeth A Campbell

National Institutes of Health (P30 CA008748)

  • Michael S Glickman

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2017, Hubin et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,175
    views
  • 942
    downloads
  • 117
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Elizabeth A Hubin
  2. Allison Fay
  3. Catherine Xu
  4. James M Bean
  5. Ruth M Saecker
  6. Michael S Glickman
  7. Seth A Darst
  8. Elizabeth A Campbell
(2017)
Structure and function of the mycobacterial transcription initiation complex with the essential regulator RbpA
eLife 6:e22520.
https://doi.org/10.7554/eLife.22520

Share this article

https://doi.org/10.7554/eLife.22520

Further reading

    1. Biochemistry and Chemical Biology
    2. Microbiology and Infectious Disease
    Stephanie M Stuteley, Ghader Bashiri
    Insight

    In the bacterium M. smegmatis, an enzyme called MftG allows the cofactor mycofactocin to transfer electrons released during ethanol metabolism to the electron transport chain.

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Cristina Paissoni, Sarita Puri ... Carlo Camilloni
    Research Article

    Both immunoglobulin light-chain (LC) amyloidosis (AL) and multiple myeloma (MM) share the overproduction of a clonal LC. However, while LCs in MM remain soluble in circulation, AL LCs misfold into toxic-soluble species and amyloid fibrils that accumulate in organs, leading to distinct clinical manifestations. The significant sequence variability of LCs has hindered the understanding of the mechanisms driving LC aggregation. Nevertheless, emerging biochemical properties, including dimer stability, conformational dynamics, and proteolysis susceptibility, distinguish AL LCs from those in MM under native conditions. This study aimed to identify a2 conformational fingerprint distinguishing AL from MM LCs. Using small-angle X-ray scattering (SAXS) under native conditions, we analyzed four AL and two MM LCs. We observed that AL LCs exhibited a slightly larger radius of gyration and greater deviations from X-ray crystallography-determined or predicted structures, reflecting enhanced conformational dynamics. SAXS data, integrated with molecular dynamics simulations, revealed a conformational ensemble where LCs adopt multiple states, with variable and constant domains either bent or straight. AL LCs displayed a distinct, low-populated, straight conformation (termed H state), which maximized solvent accessibility at the interface between constant and variable domains. Hydrogen-deuterium exchange mass spectrometry experimentally validated this H state. These findings reconcile diverse experimental observations and provide a precise structural target for future drug design efforts.